752 related articles for article (PubMed ID: 17499343)
1. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
2. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
3. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
4. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
5. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
[TBL] [Abstract][Full Text] [Related]
6. Low plasma activated protein C-protein C inhibitor complex concentration is associated with vascular access failure in hemodialysis patients.
Bakoush O; Ohlin AK; Strandberg K; Kurkus J
Nephron Clin Pract; 2008; 110(3):c151-7. PubMed ID: 18953177
[TBL] [Abstract][Full Text] [Related]
7. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
8. Are patients with thrombophilia and previous venous thromboembolism at higher risk to arterial thrombosis?
Linnemann B; Schindewolf M; Zgouras D; Erbe M; Jarosch-Preusche M; Lindhoff-Last E
Thromb Res; 2008; 121(6):743-50. PubMed ID: 17804043
[TBL] [Abstract][Full Text] [Related]
9. Activated protein C levels in Behçet's disease and risk of venous thrombosis.
Navarro S; Ricart JM; Medina P; Vayá A; Villa P; Todolí J; Estellés A; Micó ML; Aznar J; España F
Br J Haematol; 2004 Aug; 126(4):550-6. PubMed ID: 15287949
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
11. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
13. Hereditary thrombophilic risk factors and venous thromboembolism in Istanbul, Turkey: the role in different clinical manifestations of venous thromboembolism.
Okumus G; Kiyan E; Arseven O; Tabak L; Diz-Kucukkaya R; Unlucerci Y; Abaci N; Unaltuna NE; Issever H
Clin Appl Thromb Hemost; 2008 Apr; 14(2):168-73. PubMed ID: 17895505
[TBL] [Abstract][Full Text] [Related]
14. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
15. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
[TBL] [Abstract][Full Text] [Related]
16. [The Bavarian Thromboembolic Risk Cohort Study (BATER). Study protocol, state of the investigation and first results].
Schramm W; Heinemann LA; Spannagl M; Dick A; Assmann A
Dtsch Med Wochenschr; 2000 Jan; 125(1-2):2-6. PubMed ID: 10650817
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of thrombophilia and venous thromboembolism in total knee arthroplasty.
Chotanaphuti T; Ongnamthip P; Silpipat S; Foojareonyos T; Roschan S; Reumthantong A
J Med Assoc Thai; 2007 Jul; 90(7):1342-7. PubMed ID: 17710975
[TBL] [Abstract][Full Text] [Related]
18. Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
Tormene D; Simioni P; Prandoni P; Luni S; Zerbinati P; Sartor D; Franz F; Girolami A
Haematologica; 2001 Dec; 86(12):1305-9. PubMed ID: 11726323
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
[TBL] [Abstract][Full Text] [Related]
20. Early identification of acute myocardial infarction by activated protein C--protein C inhibitor complex.
Bhiladvala P; Strandberg K; Stenflo J; Holm J
Thromb Res; 2006; 118(2):213-9. PubMed ID: 16098566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]